GH1 and chronic kidney disease: However, our dose was comparable to those commonly used in rodent studies [60], and the observation of increased muscle mRNA expression of IGF-I as well as JAK/STAT phosphorylation after GH treatment in our CKD mice (Figure 5K–M) argues against any effect of GHR saturation.